Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal conditions, affecting up to 15% of the population. Treatment for IBS has largely been focused on addressing symptoms, but recent advances in research and methodology hold promise for improved assessment and treatment approaches.
These advancements include important new insights into the roles of immune activation, mast cells, microbiome imbalances, and microbial products such as histamine, serotonin, LPS, gases, and more.
In this class, practitioners will learn how advanced gastrointestinal health testing with GI-MAP can provide practitioners with important new clinical insights that facilitate improved personalization and targeting of treatment for patients with IBS.
5 LEARNING POINTS
This free course is hosted by Rupa Health — the best way to order, track, and get results from 30+ lab companies in one place.
Rupa reduces the time spent ordering labs by 90% and provides customer service for your patients around lab test collections.